Developing effective cancer vaccines: design and monitoring are critical

被引：5

作者：

Armstrong, A ^{[1
]}

Dermime, S ^{[1
]}

机构：

[1] Univ Manchester, Paterson Inst Canc Res, CRC, Dept Med Oncol, Manchester M20 4BX, Lancs, England

来源：

BRITISH JOURNAL OF CANCER | 2001年 / 84卷 / 11期

关键词：

D O I：

10.1054/bjoc.2001.1839

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1433 / 1436

页数：4

共 26 条

[11] Tumor-induced immunosuppression: A barrier to immunotherapy of large tumors by cytokine-secreting tumor vaccine [J].

Hsieh, CL ;

Chen, DS ;

Hwang, LH .

HUMAN GENE THERAPY, 2000, 11 (05) :681-692

[12] Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells [J].

Hsu, FJ ;

Benike, C ;

Fagnoni, F ;

Liles, TM ;

Czerwinski, D ;

Taidi, B ;

Engleman, EG ;

Levy, R .

NATURE MEDICINE, 1996, 2 (01) :52-58

[13]

Jager E, 1997, INT J CANCER, V71, P142, DOI 10.1002/(SICI)1097-0215(19970410)71:2<142::AID-IJC3>3.0.CO

[14]

2-0

[15]

Kaplan JM, 1999, J IMMUNOL, V163, P699

[16] DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma [J].

King, CA ;

Spellerberg, MB ;

Zhu, DL ;

Rice, J ;

Sahota, SS ;

Thompsett, AR ;

Hamblin, TJ ;

Radl, J ;

Stevenson, FK .

NATURE MEDICINE, 1998, 4 (11) :1281-1286

[17] RETRACTED: Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids (Retracted article. See vol. 9, p. 1221, 2003) [J].

Kugler, A ;

Stuhler, G ;

Walden, P ;

Zöller, G ;

Zobywalski, A ;

Brossart, P ;

Trefzer, U ;

Ullrich, S ;

Müller, CA ;

Becker, V ;

Gross, AJ ;

Hemmerlein, B ;

Kanz, L ;

Müller, GA ;

Ringert, RH .

NATURE MEDICINE, 2000, 6 (03) :332-336

[18] Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease [J].

Ludewig, B ;

Ochsenbein, AF ;

Odermatt, B ;

Paulin, D ;

Hengartner, H ;

Zinkernagel, RM .

JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (05) :795-803

[19] TOLERANCE, DANGER, AND THE EXTENDED FAMILY [J].

MATZINGER, P .

ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 :991-1045

[20] Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines [J].

Mayordomo, JI ;

Loftus, DJ ;

Sakamoto, H ;

DeCesare, CM ;

Appasamy, PM ;

Lotze, MT ;

Storkus, WJ ;

Appella, E ;

DeLeo, AB .

JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1357-1365

← 1 2 3 →